Metraipolis › archive › dc_2c4b43efa3db

Efficacy and safety of rivaroxaban plus aspirin compared with aspirin alone in patients with peripheral arterial disease: a systematic review and meta-analysis — Europe PMC PMID:42433747

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42433747
DOI
10.1097/ms9.0000000000005050
License (as archived)
solo-consultazione
Archived
2026-10-31T13:46:51.604Z
SHA-256 of the archived text
8ff46cd6bf499e7df770489892af700d5875b7e8ffb79564d0a2707881394d7d
Stable URL of this page
https://metraipolis.com/documento/dc_2c4b43efa3db

How to cite

Efficacy and safety of rivaroxaban plus aspirin compared with aspirin alone in patients with peripheral arterial disease: a systematic review and meta-analysis — Europe PMC PMID:42433747 — Europe PMC (en), https://europepmc.org/article/MED/42433747 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c4b43efa3db (Metraipolis archive dc_2c4b43efa3db, sha256 8ff46cd6bf499e7df770489892af700d5875b7e8ffb79564d0a2707881394d7d)
BibTeX
@misc{dc2c4b43efa3db,
  title = {Efficacy and safety of rivaroxaban plus aspirin compared with aspirin alone in patients with peripheral arterial disease: a systematic review and meta-analysis — Europe PMC PMID:42433747},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42433747},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c4b43efa3db; sha256 8ff46cd6bf499e7df770489892af700d5875b7e8ffb79564d0a2707881394d7d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42433747. Agents can read the archived copy with the MCP tool read_document.